A study has found that 12- to 19-year-olds of normal weight with type 1 diabetes can develop insulin resistance.

A history of severe hypoglycemia (low blood glucose) quadruples the risk for crashing a vehicle.

The cost of treating diabetes in the United States is expected to triple to $336 billion per year.

Taking first- or second-generation sulfonylureas (such as glyburide and glimepiride) was linked to a 24 to 61 percent greater risk of death compared with metformin.

Breast feeding is linked to a decreased chance of having a cluster of risk factors associated with obesity, heart disease, and diabetes.

A rheumatoid arthritis medication may protect insulin-producing beta cells.

In people with diabetes, Alzheimer’s progresses more slowly than it does in those without the disease.

Want to lose weight? Find a buddy who’s serious about losing it too.

A study found that adding a basal or a mealtime insulin to oral medication—either metformin or a sulfonylurea—helped people with type 2 control their blood glucose better.